290 related articles for article (PubMed ID: 3958492)
1. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
Hackett J; Tutt M; Lipscomb M; Bennett M; Koo G; Kumar V
J Immunol; 1986 Apr; 136(8):3124-31. PubMed ID: 3958492
[TBL] [Abstract][Full Text] [Related]
2. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
3. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
Koo GC; Dumont FJ; Tutt M; Hackett J; Kumar V
J Immunol; 1986 Dec; 137(12):3742-7. PubMed ID: 3782794
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
Hanna N; Schneider M
J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
[TBL] [Abstract][Full Text] [Related]
5. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
Savary CA; Lotzová E
J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
[TBL] [Abstract][Full Text] [Related]
6. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
7. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells.
Puzanov IJ; Bennett M; Kumar V
J Immunol; 1996 Nov; 157(10):4282-5. PubMed ID: 8906800
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells generated from bone marrow culture.
Koo GC; Peppard JR; Mark WH
J Immunol; 1984 May; 132(5):2300-4. PubMed ID: 6201540
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody 4H12 recognizes subsets of adherent-lymphokine activated killer cells and splenic natural killer cells from pregnant and neonatal mice.
Linnemeyer PA; Pollack SB
J Immunol; 1991 Jun; 146(11):3729-35. PubMed ID: 2033249
[TBL] [Abstract][Full Text] [Related]
10. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
[TBL] [Abstract][Full Text] [Related]
11. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
Savary CA; Lotzová E
J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
[TBL] [Abstract][Full Text] [Related]
13. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
Morelli L; Lemieux S
J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
[TBL] [Abstract][Full Text] [Related]
14. Generation of natural killer cell lines from murine long-term bone marrow cultures.
Yung YP; Okumura K; Moore MA
J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
Kalland T; Alm G; Stålhandshe T
J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells.
Lu L; Herberman RB; DeLeo AB
Nat Immun; 1994; 13(6):315-30. PubMed ID: 7894202
[TBL] [Abstract][Full Text] [Related]
18. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
Kung SK; Miller RG
J Immunol; 1997 Mar; 158(6):2616-26. PubMed ID: 9058794
[TBL] [Abstract][Full Text] [Related]
19. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
20. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
